MOBILITY SCOOTER (YQ-401,YQ- 401A,YQ-403,YQ-403A)
Zhejiang Kailang Technology Co., Ltd. · Decision date Sep 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-29 for K262553, a traditional 510(k) submitted by Zhejiang Kailang Technology Co., Ltd. of Yongkang, CN, received 07/24/2026. The device is listed as MOBILITY SCOOTER (YQ-401, YQ-401A, YQ-403, YQ-403A), classified under product code INI as a motorized 3-wheeled vehicle, regulation 890.3800, in the Physical Medicine specialty and review panel. SESE means clearance to market, not PMA approval.
The record shows no third-party review, no combination product designation and no authorized predetermined change control plan. The page does not identify a predicate device, summarize performance testing, or describe any component-level change, so the technical basis for the equivalence finding is not available here. The applicant's consultant is listed in Shanghai, CN.
The public record is limited to administrative fields; it does not establish clinical performance, labeling content or postmarket obligations for these scooter models.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262553
- Regulatory pathway
- 510(k) premarket notification
- Product code
- INI
- Decision code
- SESE
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vehicle, Motorized 3-Wheeled.
- Product code
- INI
- FDA device class
- 2
FDA decision timeline
K262553 received
Application receipt date recorded by FDA.
K262553 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code INI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nanjing Mijo Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 24, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 19, 2026 | FDA | |
| Zhejiang Innuovo Rehabilitation Devices Co.,Ltd | 510(k) clearance | Aug 10, 2026 | FDA | |
| Zhejiang Innuovo Rehabilitation Devices Co.,Ltd | 510(k) clearance | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhejiang Kailang Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yongkang
Sources and methodology
- Original FDA record: K262553
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

